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1. Introduction 
High-throughput protein crystallography can be a time consuming and resource intensive 
endeavor. Although recent years have seen many advances in the field, screening for 
suitable crystallization conditions using common commercially available platforms still 
requires considerable amounts of protein and reagents. Furthermore, diffraction quality 
testing and data collection typically involve physical extraction and cryogenic freezing of 
the crystal samples, which may have a significant impact on the integrity of the crystal 
(Garman, 1999). To acquire high-quality diffraction data, both the crystallization conditions 
and the cryoprotectants must be further optimized. These steps can be time consuming and 
are often restricted to experienced users (Alcorn & Juers, 2010). In response to these 
concerns, the last decade has seen a significant surge of developments in crystallography-
aimed microtechnology, specifically the use of crystallization chips. So far, the field is 
dominated by a range of microfluidic devices (Li & Ismagilov, 2010), with one of the most 
significant differences between them being the type of crystallization technique they 
employ. Several devices have been developed, and even commercialized (Topaz® 
crystallizer, Fluidigm Corp., CA, USA; The Crystal Former, Microlytic Inc., MA, USA) that 
utilize free interface diffusion (FID) (Hansen et al., 2002). Other chips employ nanochannels 
to create counter-diffusion crystallization (Hasegawa et al., 2007, Ng et al., 2008, Dhouib et 
al., 2009) or nanodroplets that simulate batch crystallization (Zheng et al., 2003). There are 
two clear, parallel implications in all these devices. They are all striving to increase 
efficiency of the hit identification process, and are offering the possibility of in situ X-ray 
analysis and, in favorable cases, diffraction data collection for structure determination 
(Zheng et al., 2004, Hansen et al., 2006, Ng et al., 2008, May et al, 2008, Dhouib et al., 2009). 
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The X-CHIP (Chirgadze, 2009) addresses the same challenges of high-throughput 
crystallography with an alternative approach, and has a number of unique additional 
advantages. In contrast to microfluidic chips, the crystallization process takes place on the 
chip surface, in droplet arrays of aqueous protein and crystallization reagents mixtures 
under a layer of oil. These microbatch arrays are made possible by altering the chip surface 
with a unique coating, creating defined areas of varying hydrophobicity.  This paper 
presents the design of the device and accompanying tools for setting up crystallization trials 
and mounting the chip for data collection, as well as the important benefits, limitations and 
implications that are inherent to this platform. It also describes proof-of-concept 
experiments in which this technology was utilized for crystal growth, visual inspection, X-
ray diffraction data collection and structure determination of two native and one 
selenomethionine-labeled protein targets. The presented results show that large, well-
diffracting crystals can be grown and high-quality data sets sufficient for structure 
determination can be collected on a home as well as a synchrotron X-ray source. 
2. X-CHIP design and application 
The principal idea behind the X-CHIP was to create a platform that presents an alternative 
to the conventional crystallographic pipeline by consolidating the processes of 
crystallization condition screening, crystal inspection and data collection onto one device, 
streamlining the entire process and eliminating crystal handling and arduous cryogenic 
techniques (Fig. 1).  
 
Figure 1. The X-CHIP was designed and developed as a miniaturized and integrated alternative to 
conventional methods of crystallization and data collection.  
The chip is made from a material chosen for its visual light transparency and relatively low 
absorption of X-ray radiation. An X-CHIP with a thickness of 0.375 mm absorbed 
approximately thirty percent of the X-ray intensity of the primary synchrotron beam that 
was attenuated by 1,800 - 2,000 times to avoid excessive radiation damage to crystals during 
data acquisition. Designed to be compatible with most standard goniometers, the device 
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inserts into a chip-base (possessing a machined slit and locking screw) for support and 
simple mounting (Fig. 1). A plastic receptacle holds multiple chips mounted on bases, 
providing rigidity for set up, storage and visual inspection of the crystallization drops and 
can be covered with a special lid to prevent dust contamination. The chip, along with 
supporting tools, is shown in Fig. 2. 
 
Figure 2. Schematics and images of the X-CHIP (a) Top-view schematic of the 24-drop format chip, 
hydrophilic and hydrophobic areas are shown in light and dark grey, respectively (other formats 
include 6-drops; not shown) (b) Cross-section of the chip (c) X-CHIP on a base and a 4-chip receptacle 
device (d) X-CHIP with 24 crystallization drops, mounted on a goniometer. 
The described system applies principles of the microbatch crystallization method, the high 
effectiveness and unique benefits of which have been described elsewhere (D'Arcy et al., 
1996, Chayen, 1998, D'Arcy et al., 2003). On the surface of the chip, circular hydrophilic areas 
are inscribed in hydrophobic annuli in ordered arrays (Fig. 2a, 2b). Nanoliter volumes of 
aqueous protein and precipitant solutions are mixed onto the hydrophilic circle by 
sequential addition and then covered by an mineral oil layer, which is dispensed on top of 
the drop and is stabilized on the surrounding hydrophobic ring. The interactions between 
the aqueous phase, oil layer and coated surface create highly defined droplets of predictable 
volume and thickness and prevent drops not only from drying but from fusing with each 
other with each other during crystallization set up and data acquisition. The design of the 
chip currently uses 1 x 6 and 4 x 6 formats and its size permits visual inspection of the entire 
chip in one image (Fig. 3a).  
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Figure 3. Experimental results: (a) section of a 4x6 X-CHIP with a two-dimensional optimization of two 
crystallization conditions for native PA0269, taken two weeks after initial set up (b) crystals of EphA3 
grown overnight, crystal size approximately 250μm in length (c) On-the-chip diffraction image for an 
EphA3 crystal, collected on a Rigaku FR-E rotating anode with R-AXIS HTC detector (d) Part of an 
experimental electron density map generated using the SAD PA0269SM data set collected directly from 
the crystal grown on the X-CHIP, superimposed with the protein Cα-trace, shown as a black solid line. 
3. Materials and methods 
Previously investigated targets, the protein kinase domain of human Ephrin Receptor 
Tyrosine Kinase A3 (EphA3) (Davis et al., 2008) and the Pseudomonas aeruginosa 
alkylhydroperoxidase D protein (PA0269) (McGrath et al., 2007) were selected as model 
proteins to demonstrate the feasibility of crystal growth and in situ data collection using 
the X-CHIP. Following several rounds of on-chip optimization, both projects were 
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crystallized at conditions similar to those in the cited literature. EphA3, at 15 mg ml-1, and 
native PA0268, at 10 mg ml-1, were crystallized using a 1:1 (vol/vol) with 0.2M (NH4)2SO4, 
0.1M Hepes pH 7.5, 25% PEG3350 and 0.8M (NH4)2SO4, 0.1M sodium citrate pH 4.0 
respectively. For crystallization drop set up, a protein sample volume of 200-250nl was 
mixed with an equal volume of precipitant solution and then covered by an mineral oil 
volume of 0.75-1.25μl; all solutions were dispensed with a Gilson P2 pipette. Prior to set 
up, the chip was inserted into the holder, which was afterward covered with a lid to 
prevent contamination. Chips were stored for 1-4 weeks at room temperature without 
significant evaporation and transported by road to the synchrotron beamline. Crystals 
both from stored chips as well as from chips set up at the synchrotron were used to collect 
diffraction data sets. 
In-house data sets were collected on a Rigaku FR-E Superbright rotating anode X-ray source 
equipped with a Rigaku R-AXIS HTC image plate as a detector (Rigaku, The Woodlands, TX, 
USA). The synchrotron data sets were collected on the IMCA-CAT ID-17 beamline at the 
Advanced Photon Source (APS) facility with appropriate beam attenuation, using the Pilatus 
6M detector (Dectris Ltd., Baden, Switzerland). The X-CHIP was manually mounted onto 
the goniometers as shown in Fig. 2d. Individual samples were initially optically centered, 
and then centered using diffraction to refine crystal position. In both cases the cryo-stream 
was blocked and data collection was performed at room temperature (~298K). 
4. Results 
Two important aspects of the described system were investigated throughout this study; the 
capacity of the chip to produce diffraction quality crystals and the feasibility of diffraction 
data acquisition (in situ) of sufficient quality for de novo structure determination. To assess 
the first task, the reproducibility of previous crystal hits obtained by sitting drop vapor 
diffusion technique was tested. For both EphA3 and PA0269 projects, vapor diffusion 
crystallization conditions resulted in high-quality crystals on the X-CHIP (Fig. 3a, 3b). For 
PA0269, on-chip optimizations further improved the crystal size and quality and decreased 
the number of crystals per drop (Fig. 3a). These results demonstrated that the X-CHIP can be 
successfully used to obtain and optimize crystallization hits and grow single crystals that 
are large enough for straightforward data collection. 
Proof-of-concept experiments for on-the-chip data collection were carried out on the 
rotating anode source and the synchrotron beamline. The initial data collection trials on the 
in-house X-ray source led to the acquisition of a complete EphA3 data set. While the 
experiment was conducted at room temperature, diffraction data could still be obtained 
with sufficient completeness, even for crystals of such low symmetry space group as P21 
(Table 1). At the synchrotron beamline, data sets for EphA3, PA0269 and a PA0269 
selenomethionine derivative (SAD) were collected. The high sensitivity and ultrafast 
readout time of the Pilatus 6M detector allowed complete data sets to be collected quickly at 
room temperature without significant degradation of the sample and with excellent 
processing statistics. Owing to the finely focused beam (50 x 50μm), it was possible to collect 
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data from multiple small crystals grown within the same drop, without any obvious impact 
on the diffraction quality of neighboring crystals. A particularly interesting result can be 
observed by comparing the mosaic spread between the X-CHIP and the benchmark data (i.e. 
cryo loop) in Table 1. It is evident that the mosaic spread was consistently lower for data set 
experiments collected using the chip, and in the case of PA0268 was as low as 0.046o. 
Furthermore, based on resolution range alone, EphA3 crystals only started showing 
radiation damage after as much as ten minutes of continuous X-ray exposure, more than 
twice the time needed for obtaining a full data set (data not shown). 
 
 EphA3 EphA3 EphA3 
PA0269
SM* 
PA0269 
PA0269S
M * 
Crystal mount 
method 
X-CHIP Cryo Loop X-CHIP 
Cryo 
Loop 
X-CHIP X-CHIP 
Sample 
Temperature (K) 
295 100 295 100 295 295 
X-ray Source Rigaku 
FR-E 
BM-17 
APS 
ID-17 
APS 
ID-17 
APS 
ID-17 
APS 
ID-17 
APS 
λ (Å) 1.54 1.00 1.00 0.97934 1.00 0.97938 
Detector R-AXIS 
HTC 
MarCCD
M300 
Pilatus 
6M 
ADSC 
Q210 
Pilatus 
6M 
Pilatus 
6M 
Space group P21 P21 P21 P6322 P6322 P6322 
Resolution (Å) 2.00 1.93 1.95 1.75 1.95 1.95 
High resolution 
shell (Å) 
(2.10-
2.00) 
(2.03-
1.93) 
(2.05-
1.95) 
(1.84-
1.75) 
(2.05-
1.95) 
(2.05-
1.95) 
Data Collection 
Time (min) 
100 29 5.3 74 3.0 3.3 
∆φtotal (o) 100† 190 160 185 90 100 
Mosaic spread (o) 0.100 1.048 0.360 0.364 0.046 0.160 
Completeness (%) 85.3† 98.4 96.2 99.8 100 100 
Multiplicity 2.4 3.6 2.7 10.6 9.5 10.3 
<I/σ(I)> 
4.5 (2.2) 12.9 (5.0) 7.5 (2.7) 
19.4 
(3.5) 
12.1 
(2.7) 
20.8 (3.9) 
Rmerge (%) 
8.8 (34.6) 4.9 (9.7) 
10.9 
(34.6) 
7.5 
(49.9) 
8.2 
(47.5) 
6.9 (50.2) 
Benchmark data is in italic font. 
Values in parentheses refer to the highest resolution shell. 
*Single-wavelength anomalous dispersion (SAD) data collection, using anomalous signal from seleno-methionine. 
† Completeness of 99% was achievable from the same set of crystals with a total oscillation angle of 140 degrees. 
Table 1. Summary of selected data sets. 
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For crystallization of EphA3 and PA0269, paraffin oil was used to coat the crystallization 
drops after protein and precipitant solution had been dispensed. Other oils have been 
explored, such as Hampton's Al's Oil (50/50 paraffin/silicon oil mixture), silicon oil and a 
50/50 mix of paratone/paraffin oils. Higher viscosity oils (paraffin, paratone/paraffin) 
performed better on the X-CHIP by being highly restricted to the hydrophobic ring 
boundaries. The thinner silicon oil was found to flow outside of these boundaries causing 
drop merging. Al's oil required more careful application compared to higher viscosity oils, 
but proved to stay within the hydrophobic boundaries. Crystallization conditions 
containing ethanol, 2-methyl-2,4-pentanediol (MPD) and detergents were also tested on the 
X-CHIP. Ethanol tolerance was tested with a 5-30% gradient using paraffin oil as a cover. 
The phase separation within the crystallization drops remained intact for the entire gradient 
range. Crystallization drops containing MPD in combination with different oils tolerated up 
to 8% before they began to disperse beyond the hydrophobic area the hydrophobic area. 
While this can exclude some MPD based conditions from being used on the X-CHIP, the 
impact on the overall versatility is low since most commercially available initial screens 
from Hampton Research and Emerald Biosystems (e.g. Wizard I&II, Index, Crystal) only 
have an average of 5-6% total conditions containing MPD. Detergent tolerance was tested 
with n-dodecyl-N,N-dimethylamine-N-oxide (DDAO) and n-octyl-β-D-glucoside in 
combination with a paraffin oil covering. Separation between the phases remained intact 
with the 0.05% n-octyl-b-D-glucoside condition but, DDAO was not tolerated even at very 
low concentrations. 
5. Discussion 
The series of initial experiments on the X-CHIP crystallization platform described above 
demonstrated the chip’s applicability for high-throughput protein crystallography and 
provided insight into the benefits and limitations of this system. Crystallization using the 
microbatch method on the chip was shown to be suitable for crystal growth and also offered 
additional benefits. Oil covered drops evaporate very slowly (days to weeks), simplifying 
both manual and automated set up. Furthermore, changing the composition of the top oil 
layer with various oil mixtures makes it possible to vary the rate of water evaporation over a 
wide range, adding another favorable dimension to crystallization screening (D'Arcy et al., 
2004). Inherently, the system is economical since crystallization hit determination and 
optimization trials require up to five times less volume of protein sample and five hundred 
times less reagent solution than standard vapor diffusion methods. Theoretically, the 
volumes can be decreased even further by incorporating robotic liquid handling systems, 
but are currently limited by the accuracy of manual dispensing. In addition, the simplicity of 
the device results in low manufacturing costs and the platform design eliminates the time 
and expenses associated with cryogenic techniques. The small size of the chip offers more 
convenient and faster visual inspection, as all the crystallization drops can be viewed under 
a microscope simultaneously. Furthermore, the system design provides a non-invasive 
means of diffraction testing and screening, as the developed device can be mounted on most 
in-house and synchrotron beamline data acquisition systems without any modification of 
 
Recent Advances in Crystallography 94 
the chip or adjustments to that system. These capabilities of the X-CHIP make it a 
potentially useful platform for high-throughput initiatives such as fragment-based screening 
by co-crystallization.  
The X-CHIP system has the potential to completely remove the “user factor” between 
crystal growth and X-ray diffraction data collection, eliminating crystal manipulation. The 
feasibility of in situ data collection has significant implications. Firstly, data collection at 
room temperature eliminates the need for the tedious and often limiting step of cryo-
condition optimization with the added advantage that crystal structures determined at 
room temperature are more representative of the physiological state. Additionally, 
experimentally obtained SAD data displayed excellent processing statistics, clearly of 
sufficient quality for de novo structure determination. Interestingly, in at least one of the 
cases investigated, undisturbed crystals have shown significantly lower mosaic spread 
than that of cryogenically frozen samples, suggesting the potential application of this 
system to samples of high sensitive or ones with a large unit cell (Table 1).  Once mounted 
on the goniometer, navigation along the chip and alignment of any crystal in the drops is 
quite straightforward, presenting the potential for data collection in a high-throughput 
mode. This approach eliminates the necessity for mounting of individual loops as in 
conventional robotics systems and may save hours of valuable synchrotron beam time. 
Finally, the elimination of manual crystal handling opens the opportunity for full 
automation of the crystallization to data acquisition pipeline allowing streamlining of the 
entire process. 
Current developments on the project are aimed at scaling down the drop volumes of the X-
CHIP system. Attempting to do so using manual set up has proven to be challenging, but 
application of a liquid handling robotics system can address this issue. The Mosquito 
crystallization robotic system (Molecular Dimensions Ltd., Suffolk, UK) has already been 
used to successfully set up crystallization experiments with total drop volumes as low as 
200nl. The X-CHIP is also being applied to the crystallization trials of additional protein 
targets. As a point of interest, experiments with highly sensitive and/or small crystal 
samples could greatly benefit from the use of this system, as the non-invasive data collection 
approach would likely resolve many problems that arise from crystal handling. We are also 
exploring the application of the chip for projects in which low mosaic spread is essential for 
successful outcome.  
6. Conclusions 
From the initial studies of the device it is evident that not only does the X-CHIP have the 
potential to increase efficiency and offer on-the-chip in situ data collection for de nevo 
structure determination, but it also has a range of additional benefits including the 
opportunity for full automation. Even though the recent growth of microchip crystallization 
technology has seen the development of several useful devices, the X-CHIP platform offers 
previously unprecedented simplicity with comparable or in some cases even better 
performance. As seen in the recent growth of commercially available and published 
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microchip crystallization devices, there is continuing interest in improving the efficiency 
and effectiveness of the diffraction pipeline. With its intuitive design, minimalistic support 
platform and compatibility with most existing beamline setups, the X-CHIP platform offers 
a new integrated tool for protein crystallization and X-ray diffraction data collection. 
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